An Allen correction and a polychromatic analysis are about equally effective in minimizing effects of interference by bilirubin and triglyceride turbidity in the direct spectrophotometry of serum hemoglobin: interference from bilirubin is nearly eliminated, that from turbidity substantially decreased. 
has been used to measure the concentration of hemoglobin in serum and plasma (3,4). Because this method is subject to interference from bilirubin, which commonly is present in increased concentration in hemolytic states, colorimetry of hemoglobin by use of benzidine (5, 6) has been preferred for many years. The Occupational Safety and Health Administration has, however, severely restricted the use of benzidine because of its carcinogenicity (7) . As a result, direct spectrophotometry of plasma hemoglobin is again popular. In addition, chromogenic assays are available that involve The most frequently cited direct spectrophotometric assay is that described by Harboe (17) . In this method an "Allen correction" (18) is used to correct for the presence of interfering substances-that is, by subtracting the background "shoulder" absorbance.
This method demonstrably eliminates interference from substances in normal sera and from mild turbidity (17) . In a study reported by Kahn et 
Materials and Methods

Reagents
In preparing hemoglobin standards we used nonlipemic blood freshly collected into tubes containing dipotassium ethylenediaminetetraacetate.
The plasma was removed and the erythrocytes were washed three times with saline (145 mmoli'L NaC1). The packed erythrocytes were re-suspended in saline and lysed by freeze-thawing three times. The hemoglobin standards and the bilirubin and triglyceride solutions were kept protected from light and refrigerated at 5-10 #{176}C.
As the diluent buffer for the procedure we used tris(hydroxymethyl)methylamine, final concentration 62.5 mmolIL, pH adjusted to 8.0 with concentrated HC1. We elected to use an alkaline diluent so as to decrease serum turbidity (21) . Hemoglobin standards and serum specimens diluted 10-fold in this diluent proved to be stable; i.e., they gave unchanged values for hemoglobin after a week of refrigerated storage.
Derivation of Polychromatic Formula
Bilirubin and triglyceride turbidity are known to be the most important sources of interference in the direct spectrophotometry of hemoglobin (4) . "Polychromatic analysis" of an analyte in the presence of two interfering substances requires that absorbance measurements be made at three separate wavelengths (22) , in the present case 380,415, and 470 nm. The first wavelength was used as a marker wavelength for triglyceride turbidity because the absorptivities of hemoglobin and bilirubin are small at that wavelength relative to that of turbidity. The second was selected because it is near an absorbance maximum for hemoglobin in alkaline medium. The last was chosen because it is near an absorbance maximum for bilirubin but absorptivity of hemoglobin is low.
The polychromatic formula was derived by solving the system of simultaneous equations that characterizes the absorbance readings at the three wavelengths in terms of the concentrations and absorptivities of hemoglobin and the interfering substances (22).
Procedures
Assay. Using plastic spectrophotometry cuvettes with a 1-cm lightpath (Evergreen Scientific, Los Angeles, CA 90058), we measured the absorbance of 0.3 mL of sample diluted with 2.7 mL of Tris buffer at the specified wavelengths (380, 415, and 450 nm for the Allen correction; 380, 415, and 470 nm for the polychromatic formula), with diluent used as the blank. Absorbances were measured at room temperature. For spectrophotometry we used a Coleman 55 Spectrophotometer (Perkin-Elmer Corp., Norwalk, CT 06856).
Calculations.
We calculated the concentrations of hemoglobin in the samples, in milligrams per liter, using the
Allen correction recommended
by Harboe and the polychromatic formula. Harboe's Allen correction (17) is
where A, A415, and A0 are the absorbance readings in milliabsorbance units at 380,415, and 450 nm, respectively, and a}0,, a15, and am are the absorptiviti#{233}s of hemoglobin in milliabsorbance units per milligram of hemoglobin per liter at 380, 415, and 450 nm, respectively. The polychromatic formula is
A380, A415, and A470 are the absorbance readings in milliabsorbance units at 380, 415, and 470 nm, respectively; am is the absorptivity of hemoglobin in milliabsorbance units per milligram of hemoglobin per liter at the indicated wavelengths; abII, is the absorptivity of bilirubin in milliabsorbance units per micromole of bilirubin per liter; and at is the relative apparent absorptivity of micellar triglyceride (actually, of scatter) in milliabsorbance units.
We calculated absorptivities for hemoglobin and bilirubin from the absorbance readings of hemoglobin and bilirubin solutions of various known concentrations. Absorbances were measured by using the described procedure.
The values for absorptivity that we entered into the spectrophotometric formulas were found by taking the average of at least five separate absorptivity calculations for each substance at each wavelength. For the stock solution of micellar triglyceride the relative apparent absorptivity at 415 urn was arbitrarily set at 10 milliabsorbance units. The relative apparent absorptivities at the other wavelengths were calculated from the ratios of the absorbance of the stock triglyceride solution at those wavelengths to its absorbance at 415 nm. We made eight absorptivity determinations at each wavelength and used the average values in the correction formulas.
Analytical Variables
Linearity.
Two sets of hemoglobin standards (100, 500, 1000, 1500, and 2000 mg/L) were measured on separate days. The results were subjected to least squares linear regression analysis (23).
Precision.
Specimens were not assayed as part of a "run" Most were selected at random but some turbid and icteric specimens were deliberately included.
Hemoglobin concentrations were measured in the original serum and in portions of serum to which we added 1/10 volume of 2000 mgfL hemoglobin stock solution. For each batch of specimens we also determined the analytical recovety in saline. Recovery from serum was calculated as the ratio of the recovery for serum matrix to recovery for saline matrix.
Interference.
The magnitude of the interference by bilirubin and turbid micellar triglyceride was determined for saline and hemoglobin solutions with concentrations of 200, 600, and 1000 mg/L. Bilirubin and micellar triglyceride were added to these solutions to give combinations of five final concentrations of bilirubin (0-0.5 moIIL) and five final concentrations of micellar triglyceride ranging from zero to the stock concentration.
Comparison of Methods and Preliminary Reference Intervals
The same serum specimens we used in the analytical recovery study were also used to compare the results of the two formulas and to construct preliminary reference intervals. The regression method of Deming was used to define the linear relationship between the results of the two methods (25). Because the imprecision of the two methods can be assumed to be equal, depending as they do upon the same absorbance measurements, the ratio of the error variances of the two methods was set equal to unity. The 
Results
Formulas
Analytical Variables
Linearity.
The Allen correction and the polychromatic formula gave values that were linearly related to hemoglobin concentration throughout the range of concentrations studied.
The linear regression equation for the data from the Allen correction is: Observed concentration were near 20%. The CVs for serum were much lower. With a one-tailed t-test at p = 0.05, the limits of detectability were 7.6 and 7.7 mgfL for the Allen and polychromatic formulas, respectively. This limit corresponds to the detection of hemoglobin in the presence of moderate bilirubin concentrations-a common and clinically important necessity. The magnitudes of detectable change in serum hemoglobin concentration were 15.8 and 15.7 mg/L for the Allen and polychromatic formulas, respectively. These values apply in the concentration range of transition to hemoglobineinia. In this study we found that the performance of the polychromatic analysis was comparable to, but no better than, the Allen correction. Hemoglobin concentration estimates found using the polychromatic formula tend to be slightly larger than those found by using the Allen correction. Both methods are simple, rapid, and inexpensive. Concentrations of hemoglobin as low as 8 mg/L can be detected, and linearity is maintained up to 2000 mgJL. At concentrations near the upper limit of the reference interval a change in concentration of 16 mg/L can be detected. This satisfies the clinical needs for analytical precision at this concentration, which is the medical decision level for the detection of intravascular hemolysis. The analytical-recovery study demonstrates that the two methods are accurate even though the interference by turbidity is not completely abolished by either method.
The reference intervals
were determined for serum specimens because serum is the usual matrix in clinical chemical assays, and is the preferred matrix in which to measure the concentrations of bilirubin, haptoglobin, and hemopexin, as well as other markers of hemolysis. The intervals found here are only preliminary, because of the small number of samples. Each laboratory should construct definitive intervals based upon a reference population appropriate to the clinical application.
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